Sienna Biopharmaceuticals Inc (SNNA):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Sienna Biopharmaceuticals Inc (SNNA) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7893
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:34
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Sienna Biopharmaceuticals Inc (Sienna Biopharmaceuticals) is a clinical-stage biopharmaceutical company that develops and commercializes topical products in medical dermatology and aesthetics. Through its topical photoparticle therapy platform, the company advanced its product SNA-001, into pivotal clinical trials for both acne vulgaris and the reduction of unwanted light-pigmented hair. SNA-120, the company’s lead candidate from topical by design platform (TBD), currently in Phase 2b clinical development, is an inhibitor of tropomyosin receptor kinase A intended for the treatment of pruritus and psoriasis. Its second TBD product candidate, SNA-125, is a dual JAK3/TrkA inhibitor being developed for the treatment of atopic dermatitis, psoriasis and pruritus. Sienna Biopharmaceuticals is headquartered in Westlake Village, California, the US.

Sienna Biopharmaceuticals Inc (SNNA) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Sienna Biopharmaceuticals Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Sienna Biopharmaceuticals Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Sienna Biopharmaceuticals Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Sienna Biopharmaceuticals Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Sienna Biopharmaceuticals Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Sienna Biopharmaceuticals Inc, Medical Equipment, Deal Details 10
Venture Financing 10
Sienna Biopharma Raises USD40 million in Series B Financing 10
Equity Offering 12
Sienna Biopharma Plans to Raise up to USD75 Million in Public Offering of Shares 12
Sienna Biopharma Raises USD74.7 Million in IPO 13
Sienna Biopharma Raises USD0.6 Million in Private Placement of Shares 15
Sienna Biopharmaceuticals Inc – Key Competitors 16
Sienna Biopharmaceuticals Inc – Key Employees 17
Sienna Biopharmaceuticals Inc – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Recent Developments 19
Financial Announcements 19
Aug 09, 2018: Sienna Biopharmaceuticals reports second quarter 2018 financial results 19
May 14, 2018: Sienna Biopharmaceuticals Reports First Quarter 2018 Financial Results 21
Mar 15, 2018: Sienna Biopharmaceuticals Reports Fourth Quarter and Full Year 2017 Financial Results 22
Nov 09, 2017: Sienna Biopharmaceuticals Reports Third Quarter 2017 Financial Results 24
Corporate Communications 25
Aug 02, 2018: Sienna Biopharmaceuticals Appoints Finance Veteran, James M. Hindman, to Board of Directors 25
Jul 02, 2018: Sienna Biopharmaceuticals Enters $40 Million Term Loan Agreement 26
Mar 22, 2018: Sienna Biopharmaceuticals Appoints Caroline Van Hove as Chief Commercial Officer 27
Mar 21, 2018: Sienna Biopharmaceuticals Appoints John W. Smither as Chief Financial Officer 28
Dec 12, 2017: Sienna Biopharmaceuticals Establishes Corporate Advisory Board 29
Jun 14, 2017: Sienna Biopharmaceuticals Appoints Erle Mast, Former CFO and Co-Founder of Clovis Oncology, to Board of Directors 30
Mar 24, 2017: Richard Peterson Joins Sienna Biopharmaceuticals As Chief Financial Officer 31
Feb 28, 2017: Former Allergan Chief David Pyott Signs on as Special Advisor to Sienna Biopharmaceuticals 32
Legal and Regulatory 33
May 07, 2018: Sebacia Announces Favorable Ruling by U.S. Court of Appeals for the Federal Circuit Regarding Patent Interference Proceedings with Sienna Biopharmaceuticals 33
Appendix 34
Methodology 34
About GlobalData 34
Contact Us 34
Disclaimer 34

List of Tables
Sienna Biopharmaceuticals Inc, Medical Equipment, Key Facts, 2017 2
Sienna Biopharmaceuticals Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Sienna Biopharmaceuticals Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Sienna Biopharmaceuticals Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Sienna Biopharmaceuticals Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Sienna Biopharmaceuticals Inc, Deals By Market, 2012 to YTD 2018 8
Sienna Biopharmaceuticals Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Sienna Biopharma Raises USD40 million in Series B Financing 10
Sienna Biopharma Plans to Raise up to USD75 Million in Public Offering of Shares 12
Sienna Biopharma Raises USD74.7 Million in IPO 13
Sienna Biopharma Raises USD0.6 Million in Private Placement of Shares 15
Sienna Biopharmaceuticals Inc, Key Competitors 16
Sienna Biopharmaceuticals Inc, Key Employees 17
Sienna Biopharmaceuticals Inc, Subsidiaries 18

List of Figures
Sienna Biopharmaceuticals Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Sienna Biopharmaceuticals Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Sienna Biopharmaceuticals Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Sienna Biopharmaceuticals Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Sienna Biopharmaceuticals Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Sienna Biopharmaceuticals Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Sienna Biopharmaceuticals Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Sienna Biopharmaceuticals Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Sienna Biopharmaceuticals Inc (SNNA):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • HNI Corporation:企業の戦略・SWOT・財務情報
    HNI Corporation - Strategy, SWOT and Corporate Finance Report Summary HNI Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • TransUnion LLC:企業の戦略・SWOT・財務分析
    TransUnion LLC - Strategy, SWOT and Corporate Finance Report Summary TransUnion LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • The Economist Group Ltd:企業の戦略的SWOT分析
    The Economist Group Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Odebrecht S.A.:企業の戦略・SWOT・財務情報
    Odebrecht S.A. - Strategy, SWOT and Corporate Finance Report Summary Odebrecht S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • SRI International:医療機器:M&Aディール及び事業提携情報
    Summary SRI International (SRI) is a non-profit organization that provides commercial research and development programs. The organization’s services include research and development, innovation consulting, technology solutions, bioscience contract research, specialized facilities and services. It pe …
  • Biosense Webster Inc:企業の製品パイプライン分析
    Summary Biosense Webster Inc (Biosense Webster), a subsidiary of Johnson & Johnson, is a medical device company that designs, manufactures and markets cardiac arrhythmias products. The company’s products include ablation catheters, diagnostic catheters and access, ultrasound catheters and 3D cardiac …
  • SHI International Corp.:企業の戦略的SWOT分析
    SHI International Corp. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • McGill University:製薬・医療:M&Aディール及び事業提携情報
    Summary McGill University (McGill) is a medical-doctoral university. The institute offers undergraduate, graduate, post-graduate courses besides research programs. It provides academic courses across various disciplines including agricultural and environmental sciences, arts, dentistry, education, e …
  • Corium International Inc (CORI):製薬・医療:M&Aディール及び事業提携情報
    Summary Corium International Inc (Corium) is a commercial-stage biopharmaceutical company that produces and develops central nervous system pharmaceutical products. The company develops transdermal healthcare products with the help of Corplex technology platform using small molecules. Its products i …
  • Checkpoint Systems, Inc.:企業の戦略・SWOT・財務情報
    Checkpoint Systems, Inc. - Strategy, SWOT and Corporate Finance Report Summary Checkpoint Systems, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Zeus Co., Ltd. (079370):企業の財務・戦略的SWOT分析
    Zeus Co., Ltd. (079370) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • LG Display Co Ltd:企業の戦略・SWOT・財務情報
    LG Display Co Ltd - Strategy, SWOT and Corporate Finance Report Summary LG Display Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Accelya Kale Solutions Limited (ACCELYA):企業の財務・戦略的SWOT分析
    Accelya Kale Solutions Limited (ACCELYA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Shelby Energy Cooperative, Inc.:企業の発電所・SWOT分析2018
    Shelby Energy Cooperative, Inc. - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on k …
  • Nexen Energy ULC:石油・ガス:M&Aディール及び事業提携情報
    Summary Nexen Energy ULC (Nexen Energy), formerly Nexen Inc., a subsidiary of CNOOC Limited, is an upstream oil and gas company that discovers and develops energy resources. It is involved in the production of conventional oil and gas, oil sands, and shale gas. The company’s activities include explo …
  • CiToxLAB Group:製薬・医療:M&Aディール及び事業提携情報
    Summary CiToxLab Group (CiToxLab) is a contract research organization that provides preclinical and specialty services. The company provides toxicology and safety pharmacology, biomarkers, pharmacokinetics, immunology services, surgical models and medical device implantation, animal efficacy models, …
  • Sanmina Corporation:企業の戦略・SWOT・財務情報
    Sanmina Corporation - Strategy, SWOT and Corporate Finance Report Summary Sanmina Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • AirStrip Technologies Inc:医療機器:M&Aディール及び事業提携情報
    Summary AirStrip Technologies Inc (AirStrip) is a healthcare solution provider that offers medical software solutions and services. The company offers mobile interoperability platform interoperability platform that offers access to critical patient data and intelligent insights across the care conti …
  • Standardkessel Baumgarte Holding GmbH:企業の戦略的SWOT分析
    Standardkessel Baumgarte Holding GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and maj …
  • Heska Corp (HSKA):企業の財務・戦略的SWOT分析
    Heska Corp (HSKA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆